These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 7826677)
1. DNA recognition by lexitropsins, minor groove binding agents. Lown JW J Mol Recognit; 1994 Jun; 7(2):79-88. PubMed ID: 7826677 [TBL] [Abstract][Full Text] [Related]
2. Ligands recognizing the minor groove of DNA: development and applications. Wemmer DE Biopolymers; 1999-2000; 52(4):197-211. PubMed ID: 11295751 [TBL] [Abstract][Full Text] [Related]
3. Molecular recognition between oligopeptides and nucleic acids: DNA sequence specificity and binding properties of thiazole-lexitropsins incorporating the concepts of base site acceptance and avoidance. Rao KE; Shea RG; Yadagiri B; Lown JW Anticancer Drug Des; 1990 Feb; 5(1):3-20. PubMed ID: 2156516 [TBL] [Abstract][Full Text] [Related]
4. Lexitropsins: rational design of DNA sequence reading agents as novel anti-cancer agents and potential cellular probes. Lown JW Anticancer Drug Des; 1988 Jun; 3(1):25-40. PubMed ID: 2838035 [TBL] [Abstract][Full Text] [Related]
5. Carbocyclic analogues of netropsin and distamycin: DNA-binding properties and inhibition of DNA topoisomerases. Bartulewicz D; Bielawski K; Bielawska A Arch Pharm (Weinheim); 2002 Nov; 335(9):422-6. PubMed ID: 12447915 [TBL] [Abstract][Full Text] [Related]
6. Progress in the design of DNA sequence-specific lexitropsins. Walker WL; Kopka ML; Goodsell DS Biopolymers; 1997; 44(4):323-34. PubMed ID: 9782774 [TBL] [Abstract][Full Text] [Related]
7. Design of sequence-specific DNA binding ligands that use a two-stranded peptide motif for DNA sequence recognition. Nikolaev VA; Grokhovsky SL; Surovaya AN; Leinsoo TA; Sidorova NYu ; Zasedatelev AS; Zhuze AL; Strahan GA; Shafer RH; Gursky GV J Biomol Struct Dyn; 1996 Aug; 14(1):31-47. PubMed ID: 8877560 [TBL] [Abstract][Full Text] [Related]
8. Molecular recognition between oligopeptides and nucleic acids. Specificity of binding of a monocationic bis-furan lexitropsin to DNA deduced from footprinting and 1H NMR studies. Lee M; Krowicki K; Shea RG; Lown JW; Pon RT J Mol Recognit; 1989 Sep; 2(2):84-93. PubMed ID: 2561528 [TBL] [Abstract][Full Text] [Related]
9. Carbocyclic analogues of lexitropsin--DNA affinity and endonuclease inhibition. Pućkowska A; Drozdowska D; Midura-Nowaczek K Acta Pol Pharm; 2007; 64(2):115-9. PubMed ID: 17665860 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of new oligopyrrole carboxamides linked with tricyclic DNA-intercalators as potential DNA ligands or topoisomerase inhibitors. David-Cordonnier MH; Hildebrand MP; Baldeyrou B; Lansiaux A; Keuser C; Benzschawel K; Lemster T; Pindur U Eur J Med Chem; 2007 Jun; 42(6):752-71. PubMed ID: 17433851 [TBL] [Abstract][Full Text] [Related]
11. Non-covalent ligand/DNA interactions: minor groove binding agents. Nelson SM; Ferguson LR; Denny WA Mutat Res; 2007 Oct; 623(1-2):24-40. PubMed ID: 17507044 [TBL] [Abstract][Full Text] [Related]
12. DNA binding properties of minor groove binders and their influence on the topoisomerase II cleavage reaction. Bell A; Kittler L; Löber G; Zimmer C J Mol Recognit; 1997; 10(6):245-55. PubMed ID: 9770648 [TBL] [Abstract][Full Text] [Related]
13. Recent developments in sequence selective minor groove DNA effectors. Reddy BS; Sharma SK; Lown JW Curr Med Chem; 2001 Apr; 8(5):475-508. PubMed ID: 11281837 [TBL] [Abstract][Full Text] [Related]
14. The binding of prototype lexitropsins to the minor groove of DNA: quantum chemical studies. Mazurek P; Feng W; Shukla K; Sapse AM; Lown JW J Biomol Struct Dyn; 1991 Oct; 9(2):299-313. PubMed ID: 1660279 [TBL] [Abstract][Full Text] [Related]
15. Energetic diversity of DNA minor-groove recognition by small molecules displayed through some model ligand-DNA systems. Lah J; Vesnaver G J Mol Biol; 2004 Sep; 342(1):73-89. PubMed ID: 15313608 [TBL] [Abstract][Full Text] [Related]
16. Sequence selectivity, cross-linking efficiency and cytotoxicity of DNA-targeted 4-anilinoquinoline aniline mustards. McClean S; Costelloe C; Denny WA; Searcey M; Wakelin LP Anticancer Drug Des; 1999 Jun; 14(3):187-204. PubMed ID: 10500495 [TBL] [Abstract][Full Text] [Related]
17. DNA sequence-selective binding of head-to-tail linked bis-lexitropsins: relation of phasing to cytotoxic potency. Guo D; Gupta R; Lown JW Anticancer Drug Des; 1993 Oct; 8(5):369-97. PubMed ID: 8251044 [TBL] [Abstract][Full Text] [Related]
18. DNA recognition by intercalators and hybrid molecules. Waring MJ; Bailly C J Mol Recognit; 1994 Jun; 7(2):109-22. PubMed ID: 7826671 [TBL] [Abstract][Full Text] [Related]
19. Sequence recognition of DNA by lexitropsins. Goodsell DS Curr Med Chem; 2001 Apr; 8(5):509-16. PubMed ID: 11281838 [TBL] [Abstract][Full Text] [Related]
20. [Specific protection of DNA by distamycin A, netropsin and bis-netropsins against the action of DNAse I]. Skamrov AV; Rybalkin IN; Bibilashvili RSh; Gottikh BP; Grokhovskiĭ SL Mol Biol (Mosk); 1985; 19(1):177-95. PubMed ID: 2984546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]